Australia's Telix Pharma Agrees to Buy Germany's ITM Isotope for About $1.65 Billion

Telix Pharmaceuticals agreed to acquire Germany-based ITM Isotope Technologies for approximately $1.65 billion to secure isotope supplies for its therapeutics pipeline. The deal values ITM shareholders' stake at around $1.25 billion in Telix shares.